CRISPR/Cas9 and TurboKnockout-Related Seminar 1: CECAD
Date: Nov 16, 2015
While genetically engineered mouse/rat models have been used widely in biomedical research, the design and generation of these models can be complicated, time-consuming and costly. In this presentation, Dr. Ouyang will briefly review the traditional pronuclear injection based transgenics and ES cell homologous recombination based gene targeting, and go over the recently developed CRISPR-mediated genome editing technology, with an emphasis on the pros and cons of each technology and their applications. He will then introduce TurboKnockout®, the newest ES-cell based gene targeting technology which allows the generation of conditional knockout/knockin mouse models in as fast as 6 months, 4-6 months shorter than the standard approach. Lastly, Dr. Ouyang will highlight a novel online tool called VectorBuilder, which promises to revolutionize the way DNA vector cloning is done.
Time: Monday, November 16, 2015
16:00 – 17:30
Location: Cologne Cluster of Excellence in Cellular Stress Responses in Aging-associated Diseases
Zülpicher Strasse 47
We will respond to you in 1-2 business days.